Skip to content
Recall Observatory FDA recall evidence

Drug product

Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-305-16

D-1149-2023

August 30, 2023

Class II

Product summary

Firm
VistaPharm LLC
Event
Event 92916
Status
Terminated
Classification
Class II
Quantity
14,400 bottles
Official record key
drug-enforcement:D-1149-2023

Official wording

Reason: Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results

Code information: Lot #: 921100; Exp. 02/2025

Distribution pattern: Distributed nationwide to 68 consignees in the U.S.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Superpotent